ArticleACS medicinal chemistry letters2026
Novel Compounds as Plasma Kallikrein Inhibitors for Treating Hereditary Angioedema, Diabetic Macular Edema, and Diabetic Retinopathy.
Ram W SabnisPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.